You are here:
Home / Latest CyberKnife VSI News
The TomoTherapy® HD® treatment system is a first-of-its-kind radiation therapy solution, integrating advanced CTrue™ imaging and 360° delivery features for greater accuracy and precision. The TomoHD system targets radiation treatment to the patient’s tumor, while helping limit damage... (Click to Read More...)
Colorado CyberKnife is pleased to announce that as of January 2012 Medicare patients living in any state treated in Colorado are now covered for the treatment of prostate cancer with CyberKnife.
Additionally – the vast majority of commercial/private insurance companies cover the treatment of... (Click to Read More...)
Offered Exclusively By Colorado CyberKnife.
We are setting the standard for compassionate care. Colorado CyberKnife offers many services that make getting to our treatment center as easy, stress-free and affordable as possible. We understand that you may not feel like dealing with details such as... (Click to Read More...)
Long Term Clinical Evidence and Worldwide Increase in Patients Treated with the CyberKnife System
SUNNYVALE, Calif., August 30, 2011 – Accuray Incorporated (Nasdaq: ARAY), the premier radiation oncology company, announced today a significant increase in use of the CyberKnife® Robotic Radiosurgery... (Click to Read More...)
July, 2011 – Colorado CyberKnife – the 1st center with the most advanced VSI model now commissioned the latest upgrade – the 9.5 Generation of Hardware & Software including Lung Optimized Treatment (L.O.T.) – eliminating the necessity of gold radiographic... (Click to Read More...)
Company’s Symposium Highlights Five-Year CyberKnife Prostate SBRT Outcomes, Demonstrates Treatment’s Long-Term Efficacy
SUNNYVALE, Calif. and Washington, D.C. – The American Urological Association (AUA) Meeting, May 16, 2011 – Accuray Incorporated (Nasdaq: ARAY), a global leader... (Click to Read More...)
This Recognition of Clinical Benefits Across Europe is Supported by Five-Year Outcomes for Low-Risk Prostate Cancer Patients Treated in Five Sessions
SUNNYVALE, Calif., May 11, 2011 – Accuray Incorporated (Nasdaq: ARAY), a global leader in the field of radiosurgery, announced today that 85... (Click to Read More...)
Study Demonstrates Long-Term Efficacy of Five-Day Course of Cyberknife Prostate Cancer Treatment.
SUNNYVALE, Calif., January 11, 2011 – Accuray Incorporated (Nasdaq: ARAY), a global leader in the field of radiosurgery, announced today the first published five-year outcomes on low risk prostate... (Click to Read More...)
New Technology Enables Treatment of Tumors Throughout the Lung Without the Need to Implant Fiducial Markers
SUNNYVALE, Calif., December 15, 2010 -Accuray Incorporated (Nasdaq: ARAY), a global leader in the field of radiosurgery, announced today that the U.S. Food and Drug Administration (FDA) has... (Click to Read More...)
Enhanced Capabilities Enable More Patients to Benefit from CyberKnife Treatment at Colorado Cyberknife.
SUNNYVALE, Calif., October 29, 2010 – Accuray Incorporated (Nasdaq: ARAY), a global leader in the field of radiosurgery, announced the feedback received from Colorado... (Click to Read More...)